Debt Repayment

KALA BIO (NASDAQ:KALA) completed a registered direct offering on Dec 5 2025, selling 10 million common shares (or pre‑funded warrants) at $1.00 each, generating roughly $10 million in gross proceeds. H.C. Wainwright acted as exclusive placement agent. Net proceeds will be used to repay indebtedness and for general corporate purposes. The offering was executed under a shelf registration (File No. 333‑270263) filed Mar 3 2023 and became effective May 11 2023.

Auxly Cannabis Group Inc. has fully repaid its $5 million inventory loan to GrassHopper Capital Inc. using existing cash reserves. This move is projected to save approximately $900,000 in annual interest expenses and reflects a strategic focus on financial discipline. The repayment allows for greater capital allocation flexibility, potentially freeing up resources for future organic growth investments. CEO Hugo Alves cited growing profitability and a stable cost base driving free cash flow as reasons for prioritizing debt reduction.

Legence (LGN) successfully completed its IPO on September 12, 2025, offering 26 million Class A shares at $28 per share. Underwriters exercised part of their option, purchasing an additional 3.48 million shares. The IPO, led by Goldman Sachs and Jefferies, generated approximately $780.2 million in net proceeds. Legence plans to use these funds to repay term loan debt and for general corporate purposes, aiming for stable growth and long-term value creation.